Life ScienceCompany
GlaxoSmithKline M&A Summary
GlaxoSmithKline has acquired 31 companies, including 6 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 24 assets.
GlaxoSmithKline’s largest acquisition to date was in 2000, when it acquired SmithKline Beecham for $75.7B. It’s largest disclosed sale occurred in 2013, when it sold Lucozade Ribena Suntory to Suntory Beverage & Food Limited for $2.1B. GlaxoSmithKline has acquired in 11 different US states, and 10 countries. The Company’s most targeted sectors include life science (81%) and healthcare services (7%).
GlaxoSmithKline Business Overview
Where is GlaxoSmithKline headquartered?
GlaxoSmithKline is headquartered in Brentford, United Kingdom.
What is GlaxoSmithKline’s revenue?
GlaxoSmithKline disclosed revenue of 34,099M GBP for 2020 and 33,754M GBP for 2019.
How many employees does GlaxoSmithKline have?
GlaxoSmithKline has 94,066 employees.
What sector is GlaxoSmithKline in?
GlaxoSmithKline is a life science company.
When was GlaxoSmithKline founded?
GlaxoSmithKline was founded in 1715.
M&A Summary
-
M&A Total Activity55
- M&A Buy Activity31
- M&A Sell Activity24
- Total Sectors Invested 5
- Total Countries Invested 10
- M&A Buy/Sell Connections 30
- M&A Advisors 9
Unlimited Searches
